Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Vericel Corporation (NQ: VCEL )

47.71 +0.63 (+1.34%)
Streaming Delayed Price Updated: 3:42 PM EDT, May 2, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Vericel Corporation

< Previous 1 2 3 4 Next >
Vericel to Report First-Quarter 2024 Financial Results on May 8, 2024
From Vericel Corporation
Via GlobeNewswire
Analyst Scoreboard: 5 Ratings For Vericel
Via Benzinga
It's A Bull Market But Harder To Pick Small Cap Biotech Winners Because Of Volatility
Biotech is in a bull market aș measured by 2023 trends with a double testing of lows on 11/23. 
Via Talk Markets
A Closer Look at 4 Analyst Recommendations For Vericel
Via Benzinga
Vericel Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Full-Year 2024 Financial Guidance
From Vericel Corporation
Via GlobeNewswire
Earnings Scheduled For February 29, 2024
Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on revenue of $276.19 million. 
Via Benzinga
HC Wainwright & Co. Maintains Buy Rating for Vericel: Here's What You Need To Know
Via Benzinga
Analyst Ratings for Vericel
Via Benzinga
Vericel to Present at the TD Cowen 44th Annual Health Care Conference on Tuesday, March 5, 2024
From Vericel Corporation
Via GlobeNewswire
3 Top Pharma Stocks for Investors Betting on a Biotech Boom
Pharma stocks offer phenomenal returns when their drug gets approved. Here are three stocks that could soar in 2024. 
Via InvestorPlace
Vericel to Report Fourth-Quarter and Full-Year 2023 Financial Results on February 29, 2024
From Vericel Corporation
Via GlobeNewswire
5 medical stocks growing earnings by triple digits
There is a little known way to pick stocks like the pros do, and today's exercise points you to five high-probability winners in a sector that's quickly turning 
Via MarketBeat
Topics Economy
Exposures Economy
Analyst Ratings for Vericel
Via Benzinga
Vericel to Present at the Canaccord Genuity Musculoskeletal Conference on Monday, February 12, 2024
From Vericel Corporation
Via GlobeNewswire
Vericel Corp. (NASDAQ: VCEL) Sets New 52-Week High in Tuesday Session
Via Investor Brand Network
Vericel Announces Preliminary Full-Year and Fourth Quarter 2023 Financial Results
From Vericel Corporation
Via GlobeNewswire
Vericel to Present at the 42nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2024
From Vericel Corporation
Via GlobeNewswire
Innovative Burn Care: MediWound Bags Additional DoD Grant For NexoBrid Development
Biopharmaceutical company MediWound Ltd (NASDAQ: MDWD) reported that the U.S. 
Via Benzinga
3 Biotech Stocks That Could Boom or Bust by 2025
Biotech stocks are popular with investors because they sometimes provide tremendous rewards. Here are three to buy for a potential payday. 
Via InvestorPlace
3 Strong Buy Stocks Set to Take Off in the Coming Months
These 3 strong buy stocks have industry experts' positive outlook and seal of approval. The only question is, are you in? 
Via InvestorPlace
Vericel Reports Third Quarter 2023 Financial Results and Raises Full-Year 2023 Financial Guidance
From Vericel Corporation
Via GlobeNewswire
Vericel to Present at the Stephens Annual Investment Conference
From Vericel Corporation
Via GlobeNewswire
Earnings Scheduled For November 8, 2023
Companies Reporting Before The Bell • Flex LNG (NYSE:FLNG) is estimated to report earnings for its third quarter. 
Via Benzinga
Vericel to Report Third-Quarter 2023 Financial Results on November 8, 2023
From Vericel Corporation
Via GlobeNewswire
Vericel Announces Publication of Positive Results from Phase 3 Debride and Protect (DETECT) Study of Thermal Burn Patients Treated with NexoBrid
From Vericel Corporation
Via GlobeNewswire
Vericel Announces U.S. Commercial Availability of NexoBrid® (anacaulase-bcdb) for the Treatment of Severe Thermal Burns in Adults
From Vericel Corporation
Via GlobeNewswire
Vericel's Short Report: Deep Dive Into Knee-Repair Focused Company's 27 Years of Losses
J Capital Research has released a short idea report on Vericel Corporation (NASDAQ: 
Via Benzinga
Vericel to Present at the Morgan Stanley Global Healthcare Conference
From Vericel Corporation
Via GlobeNewswire
As America Grapples With A Deadly Opioid Epidemic, BioRestorative Therapies Is Looking To Treat Chronic Pain Without The Need For Class-A Drugs
Chronic back pain is a significant issue in the United States, affecting millions of individuals annually. According to experts, up to 80% of the population will experience back pain at some point. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 8, 2023
Via Benzinga
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.